Skip to main content
. 2019 Jan 11;23(3):2077–2082. doi: 10.1111/jcmm.14116

Figure 2.

Figure 2

Receiver operating characteristics analysis of pleiotrophin for differentiation of patients with small cell lung cancer (SCLC) from healthy volunteers (HV) (A) and from patients with benign lung disease (BLD) (B). The analysis resulted in an area under the curve of 0.894 (patients with SCLC vs. HV) and 0.885 (patients with SCLC vs patients with BLD), respectively